Cyntegrity’s CEO Artem Andrianov to speak on the Germany ePharma day in Munich. The topic of the presentation is Practical methods how to master the new EU Clinical Trials Regulation with risk-based monitoring (RbM)

See conference’s program here. The event is focused on the new EU regulation and offers presentations about such topics as:

  • EMA olicy on publication of clinical data,
  • Public data sharing,
  • Protection of personal data,
  • Risk-based monitoring, etc.

Registration is required.

“We will be happy to meet you in Munich and discuss the modern challenges of RBM integration in the context of the new EU regulation.”

(A. Andrianov)

For more information visit: